Healthcare -
Biotechnology - NASDAQ - US
$ 22.04
-0.136 %
$ 3.74 B
Market Cap
-9.97
P/E
IMVT - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative IMVT - Immunovant, Inc.
57.3 M
LAST VALUE
2.78%
2 YEAR CAGR
950.38%
5 YEAR CAGR
0.00%
10 YEAR CAGR